Dynavax Technologies Company
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Investors
Total Funding:
1044500000
Headquarters:
Berkeley, California, United States
Funding Status:
IPO
Employee Number:
501-1000
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Debt
Last Funding Date:
2021-05-11
Investors Number:
21
Founded Date:
1996-01-01
Industry:
Tumor-Specific Antigens